EverHealth Scribe

Graded on the platform not algorithm precedent applied to ModMed, Elation Health, Oracle Health, NextGen and OmniMD, and reinforced by a second finding confirmed on 23 July: the intelligence is not EverHealth's. EverCommerce announced a strategic AI partnership with CarePilot to power native embedded AI across DrChrono, and the operating figures published for this product at launch are explicitly attributed to CarePilot data. That places EverHealth in the position this index graded C for Veradigm, distributing a third party model under its own brand. Credit where due, as with Veradigm: the partner is named publicly rather than obscured. See the separate record for CarePilot. The grade describes the mechanism, not the quality of the output.

The review gate is stated explicitly in the launch material: notes are generated within the EHR ready for provider review and approval, so approval is described as a precondition rather than a follow up. That is the safer of the two patterns this index tracks, the same order RevMaxx describes and a contrast with products that file into the chart pending review. Held at B because no acceptance rate, edit burden figure or confidence threshold is published, and because nothing was located describing what happens to a note the provider does not approve.

No accuracy figure, model card, named models or evaluation methodology located. The one useful disclosure is indirect: the parent has publicly named CarePilot as a strategic AI partner for embedded capabilities across the platform, which is more than most vendors reveal about their supply chain, but it is not stated whether Scribe itself runs on that partnership or on something else. That ambiguity is the specific question to close.

More concrete than most launch announcements and still not evidence. Two figures are reported: an average of eight minutes of documentation time saved per visit, and a 32 percent increase in same day claim submissions. Both are granular enough for a practice to test against its own data, and same day submission rate in particular is independently measurable inside a practice management system rather than being a subjective impression. Held at C because both are user reported at launch with no denominator, cohort, time period or methodology, and no study, controlled comparison or third party assessment was located.

Not assessed. No statement on audio or transcript retention, de identification or training use was located. The partner relationship makes this more pressing than usual: if a third party supplies the intelligence, a buyer needs to know whether patient audio reaches that partner and under what terms.

Not assessed. No product specific business associate agreement posture was located, and the BAA chain question extends to any AI partner supplying capability inside the platform.

Not assessed. No named or dated attestation and no trust centre located for this module in this pass.

Not a regulated medical device and none claimed or required for ambient documentation.

Nothing located. No fairness statement, subgroup analysis or accent and dialect disclosure. One precision worth recording so the record is not read as harsher than intended: the same day claims figure is a SPEED metric rather than a coding intensity one, so this product does not currently sit on the revenue optimisation gradient this index tracks through MarianaAI, Sayvant, S10.AI, Solventum and RevMaxx. Faster submission of the same claim is a different thing from a differently coded claim.

Native to DrChrono and unavailable outside it, the same shape as the other EHR native scribes here. Notes are generated within the record rather than transferred into it, which is the meaningful part, and the vendor frames the product as fitting inside the workflow clinicians already use rather than adding a second application. No integration with any other EHR is offered or implied.

Not assessed. Cloud delivered within the DrChrono platform, but no hosting region, residency option or sub processor detail was located, and the sub processor question is live given the named AI partnership.

No published rate card and no statement on whether the module is included in the DrChrono subscription or licensed separately, which is the first question for an existing customer. Notably the launch material does not take the position athenahealth took with athenaAmbient, where inclusion at no incremental charge was stated up front.

Ambulatory and bounded by the DrChrono base, which serves independent practices, with the product explicitly positioned under a brand promise aimed at that segment. No specialty count, specialty tuning claim, note format list or language coverage was located, so breadth cannot be compared against competitors that enumerate them. Launched March 2026, so the record should be refreshed once coverage claims mature.